medRxiv PreprintsInternational10 November 2026
CDC123 variants associated with developmental abnormalities alter CDC123-eIF2 subunit interactions and impair protein synthesis
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
The translation initiation factor eIF2 is an essential regulator of cellular protein synthesis with direct links to human physiology and development. Composed of eIF2, {beta}, and {gamma} subunits, eIF2 heterotrimer assembly requires the activity of its dedicated chaperone and the essential protein, CDC123. Accordingly, CDC123 is a key determinant of protein synthesis and cell growth. Previous research has demonstrated that variants in eIF2{gamma} impair neurodevelopment, and CDC123 variants of uncertain significance have recently been reported for pediatric patients with neurologic findings.
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Silent Drift and Site-level Variance in Clinical AI: Real-world performance and subgroup analysis for post-market monitoring of an FDA-cleared artificial intelligence (AI) triage tool for high-risk use case of pulmonary embolism12 November 2026
- Determinants of mpox vaccine acceptance among peri-urban residents in Sekondi-Takoradi, Western Region of Ghana: A community-based cross-sectional study12 November 2026
- Mapping disordered eating symptoms in the ABCD Study through the Eating Disorder Symptom Index12 November 2026
- Influenza Vaccination and Disease Severity Among Older Adults Hospitalized with Influenza in France: A Nationwide Cohort Study, 2016-202412 November 2026
- Associations of drinking water per- and polyfluoroalkyl substances with cause-specific mortality in men with prostate cancer12 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.